Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-10 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-15 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
MBIO | Mustang Bio | 3.45 | -0.26 | -7.01% | 226.3M |
You can purchase shares of Mustang Bio (NASDAQ: MBIO) through any online brokerage.
Other companies in Mustang Bio’s space includes: AVEO Pharmaceuticals (NASDAQ:AVEO), Kezar Life Sciences (NASDAQ:KZR) and Cogent Biosciences (NASDAQ:COGT).
The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by B. Riley FBR on 2020-12-23. The analyst firm set a price target for 13.00 expecting MBIO to rise to within 12 months (a possible 276.81% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Mustang Bio (NASDAQ: MBIO) is $3.45 last updated Thu Feb 25 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Mustang Bio.
There is no upcoming split for Mustang Bio.